Inventiva IVA
NASDAQ IVA
$3.68 +0.39 (+12.01%)
As of: Sep 30, 2026 · 3:59 PM EDT

Inventiva (IVA) Net Cash Flow (2020 - 2026)

Updated

Inventiva's Net Cash Flow came in at -$52.82 million for Q2 2026, compared with -$88.89 million a year earlier.

Analysis

Inventiva (IVA) Net Cash Flow (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Inventiva reported Net Cash Flow of -$214.42 million; for FY2025, it was $3.74 million, down 94.9% from FY2024.

  • Going back by year, Net Cash Flow was $73.1 million in FY2024, -$64.84 million in FY2023, $1.23 million in FY2022 and -$45.03 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Net Cash Flow since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -1.27 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -2.82 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 757.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 1.62 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -4.43 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -722.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 652.90 Mn
10 Inventiva 635.75 Mn 635.75 Mn - -52.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -52.82 Mn
Jun 30, 2025 93.56 Mn
Jun 30, 2024 -52.06 Mn
Jun 30, 2021 -20.66 Mn
Mar 31, 2021 2.58 Mn
Jun 30, 2020 7.03 Mn
Mar 31, 2020 12.20 Mn
API Access

Inventiva Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=IVA&period=max&api_key=YOUR_API_KEY